Polar Capital Global Healthcare Trust (PCGH)
Category Sector Equity Healthcare
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% or a dash please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.
If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell
418.00p
Buy
420.00p
6.00p (+1.45%)
Discount/Premium
+0.33%
Estimated NAV
412.652p
Prices updated at 17 Dec 2025, 13:16 GMT
| Prices minimum 15 mins delay
Prices in GBX
Investment objective
The Company’s investment objective is to generate capital growth by investing in a global portfolio of healthcare stocks.The Company seeks to achieve this objective by investing in a diversified global portfolio consisting primarily of listed equities issued by healthcare companies involved in pharmaceuticals, medical services, medical devices and biotechnology. The portfolio is expected to be diversified by factors such as geography, industry sub-sector and investment size.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, SDR Consumer facing disclosure, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Shares & trades
- Dividends
- Portfolio
- News & dates
- Trust info
- Director info
Annual performance (%)
Year | This fund | Peer group index |
|---|---|---|
| 30 Sep 14 - 30 Sep 15 | 10.45 | 22.22 |
| 30 Sep 15 - 30 Sep 16 | 18.15 | 1.03 |
| 30 Sep 16 - 30 Sep 17 | 3.44 | 7.72 |
| 30 Sep 17 - 30 Sep 18 | 13.72 | -0.09 |
| 30 Sep 18 - 30 Sep 19 | -1.35 | 16.12 |
| 30 Sep 19 - 30 Sep 20 | 7.81 | 51.10 |
| 30 Sep 20 - 30 Sep 21 | 24.55 | 4.72 |
| 30 Sep 21 - 30 Sep 22 | 10.11 | -11.75 |
| 30 Sep 22 - 30 Sep 23 | 1.92 | -14.43 |
| 30 Sep 23 - 30 Sep 24 | 18.65 | 23.92 |
| 30 Sep 24 - 30 Sep 25 | -4.94 | -7.55 |
Primary benchmark: MSCI ACWI/Health Care NR GBP enhanced
Peer group index: Morningstar IT Biotechnology & Healthcare
Trailing returns (%)
Year | This fund | Peer group index |
|---|---|---|
| 1 Day | -1.66 | -1.03 |
| 1 Month | 2.73 | 4.28 |
| 3 Months | 19.65 | 22.58 |
| 6 Months | 25.16 | 33.15 |
| 1 Year | 16.44 | 17.77 |
| 3 Years annualised | 9.23 | 5.06 |
| 5 Years annualised | 12.24 | 0.18 |
Primary benchmark: MSCI ACWI/Health Care NR GBP enhanced
Peer group index: Morningstar IT Biotechnology & Healthcare
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.